Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -142,309 | -80,033 | -125,712 | -105,305 | -13,019 |
| Depreciation Amortization | 302 | 263 | 262 | 244 | 69 |
| Accounts receivable | -1,067 | 0 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,126 | -2,931 | 3,799 | 7,052 | N/A |
| Other Working Capital | -15,227 | -12,673 | 3,058 | 15,261 | -4,494 |
| Other Operating Activity | 49,346 | 40,277 | 62,093 | 63,506 | 1,188 |
| Operating Cash Flow | $-104,829 | $-55,097 | $-56,500 | $-19,242 | $-16,255 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,233 | -8,233 | N/A | N/A | N/A |
| PPE Investments | -2,254 | -132 | -7 | -6 | 3 |
| Net Acquisitions | 250 | 250 | 2,150 | 250 | N/A |
| Investing Cash Flow | $6,229 | $-8,115 | $2,143 | $244 | $3 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 50,000 | 0 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -9,514 |
| Common Stock Issued | 107,968 | 84,938 | 57,584 | 0 | 34 |
| Dividend Paid | N/A | N/A | -157 | N/A | N/A |
| Other Financing Activity | -3,742 | -6,862 | -3,010 | 9,212 | -538 |
| Financing Cash Flow | $154,226 | $78,076 | $54,417 | $9,212 | $-10,019 |
| Beginning Cash Position | 16,625 | 1,761 | 1,701 | 11,487 | 37,949 |
| End Cash Position | 72,251 | 16,625 | 1,761 | 1,701 | 11,678 |
| Net Cash Flow | $55,626 | $14,864 | $60 | $-9,786 | $-26,271 |
| Free Cash Flow | |||||
| Operating Cash Flow | -104,829 | -55,097 | -56,500 | -19,242 | -16,255 |
| Capital Expenditure | -2,254 | -164 | -7 | -6 | N/A |
| Free Cash Flow | -107,083 | -55,261 | -56,507 | -19,248 | -16,255 |